HealthTech

Siemens Healthineers Expands U.S. Parts Inventory and L...

What You Should Know:  – Siemens Healthineers, a global medical technology compa...

Subsense Emerges from Stealth with $17M to Develop Non-...

What You Should Know:  – Subsense, Inc., a pioneering neurotechnology company an...

Validose Raises $2M to Combat Clinical Trial Non-Adhere...

What You Should Know: – Validose, a 10XBeta Venture Studio portfolio company pio...

In turnaround, Solid Bio reports promising initial data...

Solid Biosciences reported that three children with Duchenne muscular dystrophy ...

Arcus touts early kidney cancer data as Gilead declines...

Arcus Biosciences presented new Phase 1/1b data for a kidney cancer program over...

Bonus Features, ViVE Edition – February 18, 2025 – Canc...

Welcome to the special ViVE 2025 edition of Healthcare IT Today Bonus Features. ...

Septerna ends Phase 1 trial for hypoparathyroidism drug...

Plus, news about Basilea, TME Pharma and Perceive Biotherapeutics: Septerna ...

After research pivot, Biogen beefs up pipeline with Sto...

A month after Biogen signaled plans to shift its attention to "external opportun...

Will the Entire NIH be Shut Down?

If you rely on federal grants as your sole means of support, you’re tying your d...

The Overlooked Pillar of Clinical Care: Physical Therap...

Despite their measurable clinical outcomes and contributions to patient well-bei...

Eleos Raises $60M Series C to Transform Behavioral Heal...

Led by Greenfield Partners, this Investment will Accelerate New Product Offering...

Hikma takes Amarin's 'skinny label' fight to the Suprem...

Hikma Pharmaceuticals is asking the US Supreme Court to review a generic drug la...

Qualified Health Launches with $30M Seed Funding to Dev...

Qualified Health today announced its launch with $30 million in seed funding to ...

Bavarian Nordic wins FDA OK for chikungunya vaccine in ...

The FDA has approved Bavarian Nordic’s chikungunya vaccine for adolescents and a...

Subsense launches with $17M to build a noninvasive brai...

Subsense, a startup building noninvasive technology to communicate with the brai...

Algo’s topical pain treatment fails Phase 2 study with ...

AlgoTherapeutix’s topical non-opioid drug has flunked a mid-stage trial in chemo...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.